GENOCEA BIOSCIENCES, INC.·4

Mar 1, 4:17 PM ET

GENOCEA BIOSCIENCES, INC. 4

4 · GENOCEA BIOSCIENCES, INC. · Filed Mar 1, 2017

Insider Transaction Report

Form 4
Period: 2017-02-28
Poole Jonathan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-28+135,000135,000 total
    Exercise: $4.67Exp: 2027-02-28Common Stock (135,000 underlying)
Footnotes (1)
  • [F1]1. The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.

Documents

1 file
  • 4
    wf-form4_148840302314907.xmlPrimary

    FORM 4